Access cutting-edge cervical cancer treatment through this clinical trial at a research site in Mobile. Study-provided care at no cost to qualified participants.
Access cervical cancer specialists in Mobile at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cervical cancer treatment provided free
This study will have two phases: a sacituzumab tirumotecan safety run-in and a Phase 3 portion. The safety run-in phase will be used to evaluate the efficacy and safety of sacituzumab tirumotecan at the dose for evaluation in the Phase 3 portion. The purpose of this study is to compare the efficacy and safety of sacituzumab tirumotecan versus treatment of physician's choice as second-line treatment for participants with recurrent or metastatic cervical cancer in the Phase 3 portion. The primary
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this cervical cancer clinical trial in Mobile, AL
If you're searching for cervical cancer treatment options in Mobile, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Mobile research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cervical cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.